J3304 HCPCS Level II code: Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
J3304 is the HCPCS code for “Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3304Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
Short description: Inj triamcinolone ace xr 1mg
HCPCS · United States
Notes for J3304
As CMS prints them, with any note J3304 takes from the headings above it.
Note
- CMS processing note 0127: PUBLICATION 100.2, CHAPTER 15, 50.1.
Medicare details
The indicators CMS publishes with J3304 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2019
Where J3304 sits
- 1J codesDrugs administered other than orally
- 2Active code J3304Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3304 mean?
J3304 is the HCPCS code for “Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3304?
CMS lists J3304’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3304
All J codesJ3291Injection, tranexamic acid in sodium chloride, 5 mgJ3299Injection, triamcinolone acetonide (xipere), 1 mgJ3300Injection, triamcinolone acetonide (triesence), preservative free, 1 mgJ3301Injection, triamcinolone acetonide, not otherwise specified, 10 mgJ3302Injection, triamcinolone diacetate, per 5 mgJ3303Injection, triamcinolone hexacetonide, per 5 mgJ3305Injection, trimetrexate glucuronate, per 25 mgJ3310Injection, perphenazine, up to 5 mgJ3315Injection, triptorelin pamoate, 3.75 mgJ3316Injection, triptorelin, extended-release, 3.75 mgJ3320Injection, spectinomycin dihydrochloride, up to 2 gmJ3350Injection, urea, up to 40 gm